Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery

Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery

Mohammed M Mehanna,1,2 Salma M Mohyeldin,1 Nazik A Elgindy1 1Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; 2Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, LebanonCorrespondence: Mohammed M MehannaDepar...

Full description

Bibliographic Details
Main Authors:	Mehanna MM, Mohyeldin SM, Elgindy NA
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-11-01
Series:	International Journal of Nanomedicine
Subjects:	carbohydrate - inhalation - nanocomposite - rifampicin - tuberculosis
Online Access:	https://www.dovepress.com/rifampicin-carbohydrate-spray-dried-nanocomposite-a-futuristic-multipa-peer-reviewed-article-IJN

Similar Items

The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity
by: Mohyeldin SM, et al.
Published: (2016-05-01)

Effect of sepiolite on the physical properties and swelling behavior of rifampicin-loaded nanocomposite hydrogels
Published: (2009-08-01)

Polymeric Microparticles: Synthesis, Characterization and In Vitro Evaluation for Pulmonary Delivery of Rifampicin
by: Faiqa Falak Naz, et al.
Published: (2022-06-01)

Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
by: Juan M. Galdopórpora, et al.
Published: (2022-04-01)

Rifampicin-Induced Thrombocytopenia: A Rare Complication
by: Ravi Dosi, et al.
Published: (2019-01-01)

Rifampicin-induced acute thrombocytopenia
by: Banu Rekha V, et al.
Published: (2005-01-01)

A case of severe thrombocytopenia after the first exposure to rifampicin
by: Chinatsu Nakane, et al.
Published: (2023-01-01)

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
by: M.M. O'Donnel, et al.

The efficacy and tolerability of rifampicin in Burmese patients with lepromatous leprosy
by: TIN SHWE, et al.
Published: (1978-06-01)

Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
by: Jeong Moon Choi, et al.
Published: (2011-01-01)

Molecular Characterization of Rifampicin Associated Mutation in Mycobacterium tuberculosis Isolates
by: Ali Tahir, et al.
Published: (2021-06-01)

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
by: Hui Zhu, et al.
Published: (2015-01-01)

Rifampicin induced adrenal crisis in an uncommon setting
by: Animesh Ray, et al.
Published: (2013-01-01)

Influence of isoniazid on the metabolism of rifampicin on rat hepatocytes
by: Fasich Fasich, et al.
Published: (2000-06-01)

Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023-01-01)

Role of Ascorbic Acid in Portal Inflammation Induced by Rifampicin
by: Iram Tassaduq
Published: (2012-06-01)

MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters
by: Cyrus Alexander, et al.
Published: (2020-10-01)

Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
by: Kayas Derya, et al.
Published: (2004-06-01)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
by: Anna Gidari, et al.
Published: (2020-08-01)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022-11-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Effect of rifampicin on the kidney of albino rats
by: DE Peters, et al.
Published: (2013-07-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Genetic Screen Reveals the Role of Purine Metabolism in Staphylococcus aureus Persistence to Rifampicin
by: Rebecca Yee, et al.
Published: (2015-12-01)

Molecular quantification of Rifampicin-resistance in Mycobacterium tuberculosis
by: Abdulameer Abuallh Al-Mussawi, et al.
Published: (2017-07-01)

Development and Evaluation of Rifampicin Loaded Alginate–Gelatin Biocomposite Microfibers
by: Ameya Sharma, et al.
Published: (2021-05-01)

Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
by: Chi Eun Oh, et al.
Published: (2022-05-01)

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny
Published: (2009-12-01)

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny Yenny
Published: (2016-02-01)

Rifampicin-Induced Nephrotoxicity in a Tuberculosis Patient: Treatment Dilemma?
by: Antonio Grilo Novais, et al.
Published: (2021-10-01)

Evaluation of the resistance of Mycobacterium tuberculosis to rifampicin at the regional hospital center of Maradi, Niger Republic
by: Ousmane Abdoulaye, et al.
Published: (2022-01-01)

Rifampicin-induced interstitial nephritis: A case report and a short review of the literature
by: Ghouse Ahmed Khan, et al.
Published: (2016-07-01)

Study the Effect of Rifampicin in the Level of Thyroid's Gland Hormones and Thyroid - Stimulating Hormone in Rabbits
by: D. A. Sabrei
Published: (2017-08-01)

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT
by: Guy E Thwaites, et al.
Published: (2018-10-01)

Effects of intraocular rifampicin on retinal ganglion cell structure:a stereological and histopathological study
by: Özgür Cakici, et al.
Published: (2013-10-01)

Efficacy and safety of low-dose rifampicin in patients with benign intrahepatic cholestasis
by: Xiaoyan Guo, et al.
Published: (2022-09-01)

Determination of thorium(IV) with rifampicin in synthetic mixture and soil samples by spectrophotometry
by: Lutfullah, et al.
Published: (2016-11-01)

Stability of extemporaneous rifampicin prepared with X-temp® oral suspension system
by: Salma Nadirah Md Salim, et al.
Published: (2021-01-01)

Clinical and Radiological Evaluation After Chemical Synovectomy With Rifampicin in Hemophilic Arthropathy: Korean Experience With a 2-Week Interval Protocol
by: Hoon Chang Suh, et al.
Published: (2018-06-01)